For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Transactions

Mar. 13, 2001

Paul Hastings: NAVATO'S BIOMARIN GETS EQUITY INVESTMENT

BioMarin Pharmaceutical Inc. has reached an agreement with Acqua Wellington North American Equities Fund Ltd. for an equity investment in BioMarin of up to $50 million.

        BioMarin Pharmaceutical Inc. has reached an agreement with Acqua Wellington North American Equities Fund Ltd. for an equity investment in BioMarin of up to $50 million.
        Novato's BioMarin Pharmaceutical develops therapies for life-threatening genetic diseases that presently lack effective treatment options. The company is also developing treatments for patients with severe burns....

To continue reading, please subscribe.

Already a subscriber?

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.